| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |